These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 11421865)
1. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865 [TBL] [Abstract][Full Text] [Related]
2. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers. Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833 [TBL] [Abstract][Full Text] [Related]
3. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806 [TBL] [Abstract][Full Text] [Related]
4. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors. McCarthy DM Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788 [TBL] [Abstract][Full Text] [Related]
6. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin. Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510 [TBL] [Abstract][Full Text] [Related]
7. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis. Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291 [TBL] [Abstract][Full Text] [Related]
8. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review. Bustamante M; Stollman N J Clin Gastroenterol; 2000 Jan; 30(1):7-13. PubMed ID: 10636205 [TBL] [Abstract][Full Text] [Related]
14. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030 [TBL] [Abstract][Full Text] [Related]
15. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy. Yen HH; Yang CW; Su WW; Soon MS; Wu SS; Lin HJ BMC Gastroenterol; 2012 Jun; 12():66. PubMed ID: 22681960 [TBL] [Abstract][Full Text] [Related]
18. Intravenous versus oral omeprazole on patients with high risk bleeding peptic ulcers: A prospective randomized clinical trial protocol. Zhang J; Diao P; Zhang L Medicine (Baltimore); 2021 Apr; 100(14):e25136. PubMed ID: 33832076 [TBL] [Abstract][Full Text] [Related]
19. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists]. Asaka M; Kato M; Sato Y; Miyazaki T Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322 [TBL] [Abstract][Full Text] [Related]
20. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study. Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]